CECILLE CRUZ: Open Payments
NPI 1548894298 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,252 in 148 payments from 48 companies in 2025. Trend: 2023 $2,264 · 2024 $3,612 · 2025 $4,252
Food & beverage: $4,157Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $545 |
| Novartis Pharmaceuticals Corporation | 24 | $472 |
| ABBVIE INC. | 10 | $203 |
| BeOne Medicines USA, Inc. | 3 | $195 |
| Merck Sharp & Dohme LLC | 8 | $190 |
| SpringWorks Therapeutics, Inc. | 3 | $188 |
| Janssen Biotech, Inc. | 8 | $171 |
| JAZZ PHARMACEUTICALS INC. | 2 | $144 |
| E.R. Squibb & Sons, L.L.C. | 6 | $144 |
| SERVIER PHARMACEUTICALS LLC | 6 | $142 |
Products named: ENHERTU, IMFINZI, BRUKINSA, KEYTRUDA, OGSIVEO, KISQALI, ZEPZELCA, OPDIVO.
Industry payments across IL — which companies pay providers there.
